abstract |
The invention relates to compounds of general formula (I), wherein substituents A, B, D, E, Rl and R2 are defined in the description, in addition to the physiologically compatible salts thereof, methods for the production of said compounds and the use thereof as medicaments. Said compounds are kinase inhibitors, particularly inhibitors of kinase GSK-3ß (glycogensynthase kinase-3ß). |